pDC Dysfunction and Post-Viral Biology

1 Van der Sluis et al. 2022 — pDCs During COVID-19: Ally or Adversary?

Full Citation:: Van der Sluis RM, Holm CK, Jakobsen MR. Plasmacytoid dendritic cells during COVID-19: Ally or adversary? Cell Reports. 2022;40(4):111148. (Van der Sluis, Holm, and Jakobsen 2022) DOI:: 10.1016/j.celrep.2022.111148 PMID:: 35858624 Study Design:: Comprehensive narrative review Key Findings::

- 19 of 23 studies identified significant reduction of circulating pDCs during COVID-19; 10 of 13 found pDC decline proportional to disease severity ("pDC desert" phenomenon)
- pDCs sense SARS-CoV-2 via TLR7→MyD88→IRF7→IFN-alpha independently of ACE2/TMPRSS2 (not productively infected)
- SARS-CoV-2 exploits NRP1/CD304 expressed on pDCs to suppress IFN production — a virus-specific immune evasion strategy
- pDCs diversify into three functional populations: P1 (IFN-alpha-producing, PD-L1^high^CD80^low^), P2 (dual), P3 (antigen-presenting, PD-L1^low^CD80^high^)
- The "pDC desert" is documented across multiple RNA viruses (HIV, HCV, HBV) — not COVID-19-specific

Relevance:: Establishes blood pDC depletion as a consistent, severity-associated finding across respiratory viral infections. The “pDC desert” concept unifies Garcia 2024’s pDC depletion finding with a broader post-viral immunological pattern. The NRP1/CD304 immune evasion mechanism suggests SARS-CoV-2 actively impairs pDC IFN production — a mechanism that could contribute to impaired antiviral defense and failed viral clearance in post-viral ME/CFS. Certainty Assessment::

- *Quality:* High (Cell Reports; synthesises 23 independent studies)
- *Certainty:* 0.70
- *Limitation:* Review article — no original data; "pDC desert" concept is aggregative, not experimentally validated as a unified phenomenon

2 Li et al. 2017 — Disease-Associated Plasmacytoid Dendritic Cells

Full Citation:: Li S, Wu J, Zhu S, Liu YJ, Chen J. Disease-associated plasmacytoid dendritic cells. Frontiers in Immunology. 2017;8:1268. (Li et al. 2017) DOI:: 10.3389/fimmu.2017.01268 PMID:: 29085364 Study Design:: Comprehensive systematic review with disease comparison table Key Findings::

- Universal pattern across autoimmune and neoplastic diseases: blood pDCs DECREASED, tissue pDCs INCREASED
- Chemokine axes driving blood→tissue migration: CXCR3/CXCL9-11, CXCR4/CXCL12, chemerin/ChemR23, CCR7/CCL19-21
- In SLE: pDCs produce excessive IFN-I via HMGB1-TLR9-MyD88 pathway; pDCs are primary source of pathogenic IFN-I signature
- Tolerogenic pDC functions documented: IDO expression (TGF-beta-induced), granzyme B secretion (IL-3/IL-10-dependent), Treg induction via ICOSL
- pDC dysfunction patterns disease-specific: IFN-I overproduction in SLE; IFN-I suppression in cancer; IDO-mediated tolerance across multiple contexts

Relevance:: Provides the mechanistic framework for resolving the Garcia-Augustin pDC directionality contradiction: blood→tissue migration via specific chemokine axes. The documented pattern across SLE, RA, psoriasis, and cancers establishes that pDC depletion in blood with tissue expansion is an established immunological phenomenon, not a disease-specific anomaly. The CXCR3/CXCL9-11 axis is testable in ME/CFS and Long COVID. Certainty Assessment::

- *Quality:* Medium-High (Frontiers in Immunology; comprehensive review with detailed disease comparison table; well-cited)
- *Certainty:* 0.65
- *Limitation:* 2017 publication predates COVID-19 era; chemokine mechanisms confirmed in autoimmune diseases but not in post-viral conditions

3 Pérez-Gómez et al. 2021 — DC Deficiencies Persist 7 Months After SARS-CoV-2

Full Citation:: Pérez-Gómez A, Vitallé J, Gasca-Capote C, et al. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cellular & Molecular Immunology. 2021;18:2128–2139. (Pérez-Gómez et al. 2021) DOI:: 10.1038/s41423-021-00728-2 PMID:: 34290398 Study Design:: Longitudinal cohort study Key Findings::

- CD1c^+^ myeloid DCs AND pDCs remained significantly decreased 7 months post-SARS-CoV-2 infection
- Deficit present in both previously-hospitalised AND non-hospitalised patients — severity-independent persistence
- DC activation and homing markers (CCR7, CD86) altered during acute phase
- Demonstrates that pDC depletion is persistent, not a transient acute-phase phenomenon

Relevance:: Critical for temporal framing of pDC dysfunction: blood pDC depletion persists into chronic post-COVID phase, arguing against simple temporal recovery. Contradicts Augustin 2026’s tissue pDC expansion finding UNLESS migration (blood→tissue) is the primary mechanism — i.e., pDCs are persistently sequestered in tissues rather than numerically recovered. Supports the “migration hijack” model as most parsimonious explanation for the Garcia-Augustin contradiction. Certainty Assessment::

- *Quality:* High (Cellular \& Molecular Immunology, Nature portfolio; longitudinal design; peer-reviewed)
- *Certainty:* 0.65
- *Limitation:* Sample size for pDC-specific analysis not retrieved; DNase1L3 and pDC functional data not reported; single timepoint follow-up (7 months)

4 Schmid et al. 2007 — Water Immersion, Swimming, and Cardiac Output in Heart Failure

Full Citation:: Schmid JP, Noveanu M, Morger C, Gaillet R, Capoferri M, Anderegg M, Saner H. Influence of water immersion, water gymnastics and swimming on cardiac output in patients with heart failure. Heart. 2007;93(6):722–727. (Schmid et al. 2007) DOI:: 10.1136/hrt.2006.094870 PMID:: 17164483 PMCID:: PMC1955189 Study Design:: Controlled physiological study (three parallel groups) Sample Size:: n=30 (10 CHF patients, 10 CAD patients with preserved LV function, 10 healthy controls) Key Findings:

- Water immersion to chest increased cardiac index: 19% (controls), 21% (CAD patients), 16% (CHF patients)
- All groups could increase cardiac index during swimming: 87% (controls), 77% (CAD), 53% (CHF)
- Water immersion decreased heart rate in all groups (vagal activation overriding Bainbridge reflex)
- Oxygen uptake during swimming: 9.7 (3.3) ml/kg/min (CHF), 12.4 (3.5) ml/kg/min (CAD), 13.9 (4.0) ml/kg/min (controls)
- Swimming intensity below anaerobic threshold for all groups including CHF
- Peripheral vascular resistance decreased: 21% (CHF), 30% (CAD), 28% (controls) during immersion; further decrease during exercise
- Hydrostatic pressure increases central venous pressure and venous return via compression of peripheral veins

Relevance:: High relevance for ME/CFS exercise modality optimization. Demonstrates hydrostatic pressure effects on hemodynamics during aquatic exercise with key autonomic implications:

- Vagal activation (decreased HR) while maintaining or increasing stroke volume — potentially beneficial for POTS/orthostatic intolerance
- Horizontal posture in water reduces gravitational stress — may improve orthostatic tolerance during exercise
- Thermoneutral water (32°C) reduces thermal stress — important for ME/CFS patients with thermoregulatory dysfunction
- Swimming at tested intensity (~4 METs or 14 ml/kg/min VO2) below anaerobic threshold even in reduced cardiac function patients

Certainty Assessment::

- *Quality:* Medium-High (Heart/BMJ; controlled design; validated non-invasive cardiac output measurement; thermoneutral water)
- *Certainty:* 0.68
- *Limitations:* Wrong patient population (heart failure/CAD, not ME/CFS); cardiac dysfunction mechanisms differ from ME/CFS; excluded severely impaired CHF patients; acute hemodynamic response only; no long-term training outcomes; all participants were swimmers pre-study

5 Hanna et al. 1993 — Water Immersion and Exercise Response After Myocardial Infarction

Full Citation:: Hanna RD, Sheldahl LM, Tristani FE. Effect of enhanced preload with head-out water immersion on exercise response in men with healed myocardial infarction. American Journal of Cardiology. 1993;71(12):1041–1044. (Hanna, Sheldahl, and Tristani 1993) DOI:: 10.1016/0002-9149(93)90570-3 PMID:: 8475866 Study Design:: Crossover controlled study (water vs land, same subjects) Sample Size:: n=15 men with healed myocardial infarction Key Findings:

- At rest in water: Cardiac output and stroke volume elevated (p < 0.05) vs land
- During exercise (upright cycle ergometer, 40–75% peak VO2): No difference in heart rate, cardiac output, or stroke volume between water and land
- Contrast with healthy subjects: In healthy men, cardiac output and stroke volume are greater in water than on land during upright cycling; heart rate similar at below 50% peak VO2 but decreased in water at higher intensities
- Findings unchanged when excluding beta-blocker users (n=8) or subjects with ST-segment depression (n=5)
- Conclusion: MI alters normal cardiac response to increased preload during exercise; mechanism may involve reduced myocardial compliance or near-complete use of Frank-Starling reserve during land exercise

Relevance:: Medium-high relevance for ME/CFS exercise physiology. Demonstrates that altered autonomic/cardiac physiology changes response to hydrostatic preload:

- Normal subjects use enhanced preload to increase stroke volume during water exercise; compromised physiology (MI, potentially ME/CFS autonomic dysfunction) fails to utilize this reserve
- Upright cycling during immersion still did not benefit from hydrostatic preload — suggests simply being in water is insufficient if autonomic/cardiac adaptation is impaired
- ME/CFS/POTS patients may similarly have reduced ability to utilize preload augmentation, potentially limiting aquatic exercise benefit
- Safety implication: Water immersion did not worsen exercise response even in compromised physiology — supports aquatic exercise as safe option if tolerance established

Certainty Assessment::

- *Quality:* Medium (American Journal of Cardiology; crossover design; validated cardiac output measurement)
- *Certainty:* 0.55
- *Limitations:* Wrong patient population (healed myocardial infarction, not ME/CFS); all male; upright cycling in water (not swimming); no assessment of symptoms or perceived exertion; acute exercise only

References

Hanna, R. D., L. M. Sheldahl, and F. E. Tristani. 1993. “Effect of Enhanced Preload with Head-Out Water Immersion on Exercise Response in Men with Healed Myocardial Infarction.” American Journal of Cardiology 71 (12): 1041–44. https://doi.org/10.1016/0002-9149(93)90570-3.
Li, Shuang, Jing Wu, Shan Zhu, Yong-Jun Liu, and Jingtao Chen. 2017. “Disease-Associated Plasmacytoid Dendritic Cells.” Frontiers in Immunology 8: 1268. https://doi.org/10.3389/fimmu.2017.01268.
Pérez-Gómez, Alberto, Joana Vitallé, Carmen Gasca-Capote, et al. 2021. “Dendritic Cell Deficiencies Persist Seven Months After SARS-CoV-2 Infection.” Cellular & Molecular Immunology 18: 2128–39. https://doi.org/10.1038/s41423-021-00728-2.
Schmid, Jean-Paul, Markus Noveanu, Cyrill Morger, Raymond Gaillet, Mauro Capoferri, Matthias Anderegg, and Hugo Saner. 2007. “Influence of Water Immersion, Water Gymnastics and Swimming on Cardiac Output in Patients with Heart Failure.” Heart 93 (6): 722–27. https://doi.org/10.1136/hrt.2006.094870.
Van der Sluis, Renée Marije, Christian Kanstrup Holm, and Martin Roelsgaard Jakobsen. 2022. “Plasmacytoid Dendritic Cells During COVID-19: Ally or Adversary?” Cell Reports 40 (4): 111148. https://doi.org/10.1016/j.celrep.2022.111148.